You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

 

Online download statistics by month:

Online download statistics by month: August 2021 to August 2024

AbstractFullPdf
Aug 202155255299
Sep 2021562567140
Oct 202119619647
Nov 202113813931
Dec 202112813023
Jan 2022859127
Feb 202210410822
Mar 202211313264
Apr 2022879239
May 2022869253
Jun 2022858532
Jul 2022989953
Aug 2022899037
Sep 2022929345
Oct 2022939540
Nov 2022555736
Dec 2022323320
Jan 2023505023
Feb 2023737348
Mar 2023404234
Apr 2023374033
May 2023353518
Jun 2023343421
Jul 2023292932
Aug 2023363627
Sep 2023303022
Oct 2023444416
Nov 2023495125
Dec 2023424227
Jan 2024616233
Feb 2024696937
Mar 2024646988
Apr 2024373732
May 2024454534
Jun 2024545328
Jul 2024656635
Aug 2024414215
Total353036001436